Sign in
MI

MediaAlpha, Inc. (MAX)·Q3 2025 Earnings Summary

Executive Summary

  • Q3 delivered strong topline and profitability: revenue $306.5M (+18% y/y), Adjusted EBITDA $29.1M (+11% y/y), net income $17.6M; Transaction Value (TV) reached $589.3M (+30% y/y), with P&C TV up 41% to $548.2M .
  • Results beat Wall Street consensus: revenue $306.5M vs $283.4M est; Primary EPS 0.404 vs 0.202 est (S&P Global). Management exceeded the high end of its Q3 guidance and authorized a new $50M share repurchase, after buying back 3.2M shares for $32.9M in September .
  • Mix and margins: Gross margin 14.2% (vs 15.1% y/y) and Contribution Margin 14.9% (vs 16.0%) on higher Private Marketplace mix and lower under‑65 health; Adjusted EBITDA margin 9.5% (vs 10.1% y/y) .
  • Q4 guide: TV $620–$645M (+27% y/y midpoint), revenue $280–$300M (~4% y/y decline midpoint) and Adjusted EBITDA $27.5–$29.5M (~22% y/y decline midpoint) as under‑65 health remains a headwind; take rate expected ~7% with Private Marketplace ~54% of TV .
  • Stock catalysts: continued broadening of P&C carrier demand (potential mix shift back to Open Marketplace), stabilization in health and any signs of take-rate inflection above ~7% in 2026, plus capital returns via the $50M buyback authorization .

What Went Well and What Went Wrong

  • What Went Well

    • P&C momentum: P&C TV +41% y/y to $548.2M; management sees early stages of a multi‑year soft market with robust carrier growth budgets and expects continued gains .
    • Beat vs consensus and guidance: Revenue and EPS exceeded S&P Global consensus; Q3 results exceeded high end of company guidance; management highlighted stronger demand and share gains .
    • Capital Rolling capital return and strong cash generation: Free cash flow $23.6M in Q3 (81% of Adjusted EBITDA per letter) with net debt/Adj. EBITDA <1x; new $50M repurchase authorization after $32.9M repurchase in Sept .
    • Management quote: “We delivered record third quarter results… More auto insurance carriers are focusing on growth… We expect sustained growth in our P&C vertical…” — Steve Yi, CEO .
  • What Went Wrong

    • Mix pressure on margins: Gross margin fell to 14.2% (15.1% y/y) and Contribution Margin to 14.9% (16.0% y/y) on lower under‑65 and higher Private Marketplace mix in P&C, compressing take rates .
    • Health vertical down: Health TV fell 40% y/y to $33.5M; under‑65 health expected to contribute only $1–$2M in Q4 and remain mid‑single‑digit million annually near-term after FTC‑driven compliance reset .
    • Q4 guide implies margin pressure: Despite TV growth (+27% y/y midpoint), revenue guided down ~4% and Adjusted EBITDA down ~22% y/y (midpoints), reflecting mix shift and under‑65 drag; take rate guided ~7% .

Financial Results

Summary metrics (GAAP unless noted)

MetricQ3 2024Q2 2025Q3 2025
Revenue ($M)$259.1 $251.6 $306.5
Net Income ($M)$11.9 $(22.5) $17.6
Diluted EPS (GAAP)$0.17 $(0.33) $0.26
Adjusted EBITDA ($M)$26.3 $24.5 $29.1
Gross Margin (%)15.1% 15.0% 14.2%
Contribution Margin (%)16.0% 15.8% 14.9%
Transaction Value ($M)$451.8 $480.8 $589.3

Consensus vs Actual (S&P Global)

Metric (Q3 2025)ConsensusActualSurprise
Revenue ($M)283.4*306.5 Beat
Primary EPS0.202*0.404*Beat

*Values retrieved from S&P Global.

Segment details

  • Revenue by Vertical (Q3 2025)
VerticalRevenue ($M)
Property & Casualty$287.8
Health$12.9
Life$5.6
Other$0.3
  • Transaction Value by Vertical
($M)Q3 2024Q3 2025
P&C$387.5 $548.2
Health$55.6 $33.5
Life$6.3 $7.3
Other$2.4 $0.3
Total TV$451.8 $589.3

Key KPIs

KPIQ3 2024Q3 2025
Clicks % of TV88.6% 92.2%
Calls % of TV6.6% 2.8%
Leads % of TV4.8% 5.0%
Contribution ($M)$41.5 $45.6
Adj. EBITDA Margin (%)10.1% 9.5%
Cash & Restricted Cash ($M)$38.8 cash; $33.5 restricted

Notes:

  • P&C revenue rose 31% y/y to $287.8M; Health revenue fell 61% to $12.9M; Life +7% to $5.6M .
  • Management cited take-rate pressure from greater Private Marketplace mix and under‑65 health declines; Open Marketplace take rates remained relatively stable .

Guidance Changes

MetricPeriodPrevious GuidanceCurrent GuidanceChange
Transaction ValueQ4 2025N/A$620–$645M New issuance
RevenueQ4 2025N/A$280–$300M New issuance
Adjusted EBITDAQ4 2025N/A$27.5–$29.5M New issuance
Under‑65 Health TV Δ (y/y)Q4 2025N/A$(34)–$(38)M (61%–68%) New issuance
Under‑65 Health Contribution Δ (y/y)Q4 2025N/A$(8)–$(9)M (80%–90%) New issuance
Take Rate (Contribution/TV)Q4 2025N/A~7% (company expectation) New disclosure
Mix: Private Marketplace as % TVQ4 2025N/A~54% (company expectation) New disclosure

Additional corporate action: New $50M share repurchase authorization (expected completion by end of 2026; may be altered/discontinued). Repurchased ~3.2M shares for $32.9M in September ($10.17/sh) .

Earnings Call Themes & Trends

TopicQ1 2025 (Apr)Q2 2025 (Aug)Q3 2025 (Oct)Trend
P&C cycle & demandStrong P&C; early soft-market; robust carrier spend; tariffs a watch item P&C TV +71% y/y; budgets strong; tariffs manageable; new supply wins P&C TV +41% y/y; 13 carriers >$1M/mo; multi‑year soft market expected Strengthening/broadening into 2026
Take rate & mix (Open vs Private)Mix may skew Private near term; expect shift back to Open as demand broadens Take-rate compression from higher Private and new supply at lower rates Q4 take rate guided ~7%; Private ~54%; expect gradual Open shift as more carriers ramp Near-term pressure; medium-term upside
Health: under‑65Scale back under‑65; refocus on Medicare FTC settlement announced; under‑65 reset; 2025 TV $95–$100M, Contribution ~$10–$11M Under‑65 Q4 Contribution $1–$2M; mid‑single‑digit million annually in 2026; compliance implemented incl. AI monitoring Stabilizing at lower baseline
Regulatory/legal (FTC)Ongoing discussions; $5M reserve Settlement resolved for $45M; legal add-backs noted $33.5M paid; $11.5M due Q1’26; minimal Q3 legal expense Overhang largely removed
AI/technologyAI to reshape traffic; MAX expects resilience and to leverage AI for productivity Emerging positive lever
Tariffs/macroTariffs could pressure later in 2025 Seen as manageable; carrier profitability robust Not a binding constraint; demand outlook intact Diminishing concern

Management Commentary

  • Strategic positioning: “We delivered record third quarter results… We expect sustained growth in our P&C vertical as these increases continue, with broader participation in our marketplace having a positive effect on our profitability.” — Steve Yi, CEO .
  • Soft-market dynamics: “Peak underwriting profitability… tells us we’re just kicking off the heart of the soft market cycle… soft market cycles historically have been five to seven years on average.” — Steve Yi .
  • Take rate outlook: “We expect our Q4 take rate to be approximately 7%, with Private Marketplace transactions representing ~54% of total transaction value.” — Pat Thompson, CFO .
  • Health under‑65 baseline: “It’s a business that should make us $1 or $2 million in Q4, and we believe it’ll be a mid‑single‑digit million‑dollar contribution business for us next year.” — Pat Thompson .
  • AI commentary: “AI may disrupt traffic patterns… Because our marketplace spans hundreds of publishers… we expect our ecosystem to adapt well… We’re also leveraging AI to enhance productivity.” — Steve Yi .

Q&A Highlights

  • Sustainability of carrier profitability and spend: Management sees peak margins as the beginning of a multi‑year soft market, not a peak in advertising; expects broader carrier participation in 2026; cited 13 carriers spending >$1M/month, an all-time high for MAX .
  • Take rate and mix: Near-term take rate ~7% as Private Marketplace (~54% of TV) remains elevated; as more carriers ramp (especially outside top few), spend should shift to Open Marketplace, improving take rate over time .
  • Health trajectory: Under‑65 materially re‑based; $1–$2M Contribution in Q4; compliance framework includes AI-based monitoring; longer-term opportunity centered on Medicare Advantage as the market normalizes .
  • Capital allocation: Completed $32.9M buyback; new $50M authorization; flexibility to invest organically/inorganically while maintaining conservative leverage .
  • Visibility into Q4/2026: Encouraging 2026 budget discussions with broader carrier participation; Q4 guide based on strong momentum and mix assumptions (54% Private) .

Estimates Context

  • Q3 2025 results vs S&P Global consensus: revenue $306.5M vs $283.4M est; Primary EPS 0.404 vs 0.202 est — both beats (S&P Global). Management’s Q4 revenue and EBITDA guidance suggest analysts may raise P&C volume assumptions but temper margin/take-rate trajectories given Private mix and under‑65 drag .
  • Note: S&P “Primary EPS” differs in methodology from GAAP diluted EPS ($0.26 GAAP in Q3); use caution when comparing across definitions .

Values marked with an asterisk are retrieved from S&P Global.

Key Takeaways for Investors

  • P&C strength remains the core driver; TV +41% y/y with multi‑year soft-market tailwinds and broader carrier participation expected in 2026, positioning for sustained growth .
  • Near-term margin pressure is mix-driven: higher Private Marketplace share and under‑65 declines compress take rate and margins; management guides Q4 take rate ~7% with ~54% Private mix .
  • Health under‑65 headwind largely re‑based; Q4 Contribution $1–$2M and mid‑single‑digit million annually thereafter, reducing volatility; Medicare remains a long-term opportunity as digital adoption rises .
  • Strong cash generation and balance sheet flexibility: FCF conversion solid; net debt/Adj. EBITDA <1x; capital returns via a $50M repurchase authorization offer downside support .
  • Watch for catalysts: (1) evidence of demand broadening beyond top carriers, (2) shift back toward Open Marketplace, (3) take-rate inflection above ~7%, (4) improving Medicare demand into future AEP cycles .
  • Guidance setup: Q4 TV growth (+27% y/y midpoint) but revenue/EBITDA guide down y/y underscores mix headwinds; upside if Open mix increases faster-than-expected or under‑65 stabilizes sooner .
  • Legal overhang resolved: FTC settlement substantially behind the company; minimal Q3 legal expense and payments scheduled, improving clarity on forward earnings quality .

Additional Materials Read

  • Q3 2025 press release and 8‑K with exhibits (including shareholder letter) .
  • Q3 2025 earnings call transcript (full) .
  • Prior quarters for trend analysis: Q2 2025 press release and call ; Q1 2025 8‑K and call .
  • Other relevant press release in period: “MediaAlpha To Report Third Quarter Financial Results on October 29, 2025” .